REFERENCES
- Dietert R. R., Lee J. E., Bunn T. L. Developmental immunotoxicology: Emerging issues. Human Exp. Toxicol. 2003; 21: 479–485
- Holladay S. D., Smialowicz R. J. Development of the murine and human immune system: Differential effects of immunotoxicants depend on time of exposure. Environ. Health Perspect. 2000; 108(S3)463–473
- Holsapple M. P. The plaque-forming cell (PFC) response in immunotoxicology: An. approach to monitoring the primary effector function of B-lymphocytes. Methods in Immunotoxiclogy, Volume I, G. R. Burleson, J. H. Dean, A. E. Munson. Wiley-Liss, Inc., New York 1995; 71–108
- Holsapple M. P., Burns-Naas L., Hastings K., Ladics G. S., Lavin A. L., Makris S., Yang Y., Luster M. A testing framework for developmental immunotoxicology (DIT): Roundtable discussion. Toxicol. Sci. 2005; 83: 18–24
- Ladics G. S., Nicastro S. C., Smith C., Bunn T. L., Dietert R. R., Anderson P. K., Wiescinski C. M., Holsapple M. P. Characterization of an approach to developmental immunotoxicology assessment in the rat using SRBC as the antigen. Toxicol. Meth. 2000; 10: 283–311
- Ladics G. S., Smith C., Heaps K., Elliott G., Slone T., Loveless S. E. Possible incorporation of an immunotoxicological functional assay for assessing humoral immunity for hazard identification purposes in rats on standard toxicology studies. Toxicology 1995; 96: 225–238
- Ladics G. S., Smith C., Loveless S. E., Green J. W., Flaherty D., Gross C., Shah R., Williams W., Smialowicz R. Phase two of an interlaboratory evaluation of the quantification of rat splenic lymphocyte subtypes using immunofluorescent staining and flow cytometry. Toxicol. Meth. 1998; 8: 87–104
- Loveless S. E., Ladics G. S., Smith C., Holsapple M. P., Woolhiser M. R., White K. L., Musgrove D. L., Smialowicz R. J., Williams W. C. Interlaboratory study of the primary antibody response to sheep red blood cells in outbred rodents following exposure to cyclophosphamide or dexamethasone. J. Immunotoxicol. 2007, (in press)
- Luster M. I., Munson A. E., Thomas P. T., Holsapple M. P., Fenters J. D., White K. L., Jr., Lauer L. D., Germolec D. R., Rosenthal G. J., Dean J. H. Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice. Fundam. Appl. Toxicol. 1988; 1: 2–19
- Luster M. I., Portier C., Pait D. G., White K. L., Jr., Gennings C., Munson A. E., Rosenthal G. J. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 1992; 18: 200–210
- Temple L., Kawabata T. T., Munson A. E., White K. L., Jr. Comparison of ELISA and plaque-forming cell assays for measuring the humoral immune response to SRBC in rats and mice treated with benzo(a)pyrene or cyclophosphamide. Fundam. Appl. Toxicol. 1993; 21: 412–419
- USEPA. Health Effects Test Guidelines. OPPTS 870.7800. Immunotoxicity. 1998, http.//www.epa.gov/opptsfrs/publications/OPPTSHarmonized/870_Health_Effect_Test_Guidelines/Series/870-7800.pdf